Literature DB >> 29733246

Treating Tobacco Use in Patients with Incurable Malignancies: Should We Even Start the Conversation?

Susan Trout1, Adam O Goldstein1, Lawrence Marks1, Carol Ripley-Moffitt1.   

Abstract

BACKGROUND: Clinical practice guidelines recommend that all medical providers address tobacco use with patients, as the long-term health benefits of becoming tobacco free are well documented. What happens, though, when a patient has an incurable malignancy and, therefore, will not reap the long-term benefits? Clinical Consideration: Our case study encourages providers to consider the relevance of tobacco use treatment for those with incurable diseases. DISCUSSION: Although long-term benefits will not provide realistic motivation, other equally important rewards (e.g., decreased shortness of breath), a sense of accomplishment shared by patients and family, and the ability to exert control over a behavior can be equally motivating for some patients.

Entities:  

Keywords:  cancer; nicotine; oncology; palliative care; smoking; terminal illness; tobacco cessation; tobacco treatment; tobacco use

Mesh:

Year:  2018        PMID: 29733246      PMCID: PMC6425924          DOI: 10.1089/jpm.2017.0304

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  22 in total

1.  Cancer diagnosis: An opportune time to help patients and their families stop smoking?

Authors:  G Ozakinci; M Wells; B Williams; A J Munro; P Donnelly
Journal:  Public Health       Date:  2010-07-13       Impact factor: 2.427

2.  Motivational interviewing.

Authors:  Stephen Rollnick; Christopher C Butler; Paul Kinnersley; John Gregory; Bob Mash
Journal:  BMJ       Date:  2010-04-27

3.  Meta-analysis of the efficacy of tobacco counseling by health care providers.

Authors:  Sherri Sheinfeld Gorin; Julia E Heck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-12       Impact factor: 4.254

4.  Ten things that motivational interviewing is not.

Authors:  William R Miller; Stephen Rollnick
Journal:  Behav Cogn Psychother       Date:  2009-03

5.  Tobacco cessation and control a decade later: American society of clinical oncology policy statement update.

Authors:  Nasser Hanna; James Mulshine; Dana S Wollins; Courtney Tyne; Carolyn Dresler
Journal:  J Clin Oncol       Date:  2013-07-29       Impact factor: 44.544

6.  Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer.

Authors:  Mary E Cooley; Karen M Emmons; Robert Haddad; Qian Wang; Marshall Posner; Raphael Bueno; Tiffany-Jen Cohen; Bruce E Johnson
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

7.  The association between patient-reported receipt of tobacco intervention at a primary care visit and smokers' satisfaction with their health care.

Authors:  Molly B Conroy; Nicola E Majchrzak; Susan Regan; Caroline B Silverman; Louise I Schneider; Nancy A Rigotti
Journal:  Nicotine Tob Res       Date:  2005-04       Impact factor: 4.244

Review 8.  Taking care of smoker cancer patients: a review and some recommendations.

Authors:  R Mazza; M Lina; R Boffi; G Invernizzi; C De Marco; M Pierotti
Journal:  Ann Oncol       Date:  2010-01-20       Impact factor: 32.976

9.  Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting.

Authors:  Vani Nath Simmons; Erika B Litvin; Riddhi D Patel; Paul B Jacobsen; Judith C McCaffrey; Gerold Bepler; Gwendolyn P Quinn; Thomas H Brandon
Journal:  Patient Educ Couns       Date:  2009-10-20

10.  Smoking cessation counseling beliefs and behaviors of outpatient oncology providers.

Authors:  Kathryn E Weaver; Suzanne C Danhauer; Janet A Tooze; A William Blackstock; John Spangler; Leslie Thomas; Erin L Sutfin
Journal:  Oncologist       Date:  2012-02-14
View more
  1 in total

1.  Change in Health-Related Quality of Life Among Individuals With Cancer Undergoing Smoking Cessation Treatment Involving Varenicline.

Authors:  Julia R May; Nancy C Jao; Kristen McCarter; Elizabeth Klass; Timothy Pearman; Frank Leone; Robert A Schnoll; Brian Hitsman
Journal:  Oncol Nurs Forum       Date:  2021-01-04       Impact factor: 2.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.